Mark Street-Docherty

Mark Street-Docherty

We were a ticking time bomb!

When the Elucigene brand was purchased from a large MedTech company, they had six months to establish a Manchester manufacturing facility for their genetic testing kits before their stock ran out. CEO Mark Street-Docherty tells Suzy Jackson how they diffused the bomb.

Investment supports growth at Lucion Services

Lucion’s Lee Kerridge (r) and Charles Pickles at the newly expanded Gateshead laboratory facility

Investment supports growth at Lucion Services

A Gateshead-based firm which specialises in asbestos management services has announced investment in its technical capabilities to meet growing demand.

Crawford Healthcare secures new US contract

Richard Anderson, Crawford Healthcare

Crawford Healthcare secures new US contract

Crawford Healthcare, the advanced wound care company, has announced a significant milestone for its U.S. business, Crawford Healthcare Inc.

Riverside targets 40 new jobs and £2m sales

L/R: Jon Mannion (ETG) with Alan Wade (Riverside Medical Packaging)

Riverside targets 40 new jobs and £2m sales

The healthcare packaging specialist is targeting a £2m sales drive and the creation of up to 40 new jobs after globally launching its latest technology.